Education
About Us
Working with TipRanks
Follow Us
Perspective Therapeutics (CATX)
:CATX
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Jun 22 | Jun 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 1.43M | $ 7.10M | $ 10.79M | $ 10.05M |
| Gross Profit | $ 0.00 | $ 1.43M | $ 1.63M | $ 4.62M | $ 5.12M |
| Operating Income | $ 10.46M | $ -40.94M | $ -15.18M | $ -7.39M | $ -3.44M |
| EBITDA | $ 10.46M | $ -39.96M | $ -14.84M | $ -7.39M | $ -3.43M |
| Net Income | $ -79.28M | $ -46.51M | $ -14.67M | $ -7.15M | $ -3.19M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 226.92M | $ 9.24M | $ 43.76M | $ 55.89M | $ 63.83M |
| Total Assets | $ 341.10M | $ 97.89M | $ 58.09M | $ 64.44M | $ 70.42M |
| Total Debt | $ 2.38M | $ 2.55M | $ 0.00 | $ 524.00K | $ 776.00K |
| Net Debt | $ -59.20M | $ -6.69M | $ -20.99M | $ -55.37M | $ -63.05M |
| Total Liabilities | $ 50.43M | $ 22.71M | $ 3.45M | $ 3.16M | $ 3.01M |
| Stockholders' Equity | $ 290.67M | $ 75.18M | $ 54.64M | $ 61.28M | $ 67.41M |
| Cash Flow | |||||
| Free Cash Flow | $ -72.71M | $ -37.98M | $ -12.47M | $ -7.98M | $ -3.22M |
| Operating Cash Flow | $ -18.29M | $ -36.91M | $ -12.17M | $ -7.71M | $ -2.84M |
| Investing Cash Flow | $ -218.93M | $ 24.37M | $ -57.68M | $ -284.00K | $ -410.00K |
| Financing Cash Flow | $ 289.38M | $ 785.00K | $ 56.00K | $ 56.00K | $ 64.68M |